Experiences with E-39 in the treatment of advanced malignant neoplasms.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms
D000970:Antineoplastic Agents
CYTOTOXIC DRUGS/therapeutic use